These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7513362)

  • 1. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    Terleckyj I; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.
    Okumura K; Ujike H; Akiyama K; Kuroda S
    J Neural Transm (Vienna); 1996; 103(10):1153-61. PubMed ID: 9013402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
    Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands.
    Rao TS; Mick SJ; Cler JA; Emmett MR; Dilworth VM; Contreras PC; Gray NM; Wood PL; Iyengar S
    Brain Res; 1991 Oct; 561(1):43-50. PubMed ID: 1686745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
    Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
    Itzhak Y; Martin JL; Black MD; Ali SF
    Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
    Bejanian M; Pechnick RN; Bova MP; George R
    J Pharmacol Exp Ther; 1991 Jul; 258(1):88-93. PubMed ID: 1677044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.
    Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ
    J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma ligand-induced emesis in the pigeon.
    Hudzik TJ
    Pharmacol Biochem Behav; 1992 Jan; 41(1):215-7. PubMed ID: 1347173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice.
    Sonsalla PK; Riordan DE; Heikkila RE
    J Pharmacol Exp Ther; 1991 Feb; 256(2):506-12. PubMed ID: 1671596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation.
    Robson MJ; Seminerio MJ; McCurdy CR; Coop A; Matsumoto RR
    Pharmacol Rep; 2013; 65(2):343-9. PubMed ID: 23744418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
    Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
    Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characteristics of hyperambulation induced by the sigma ligand (+)-3-PPP in rats.
    Hirotsu I; Koyama M; Honbo N; Ohno T
    Jpn J Pharmacol; 1994 May; 65(1):1-7. PubMed ID: 7916383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
    Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
    Itzhak Y; Martin JL; Ali SF
    Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
    Matthews RT; McMillen BA; Sallis R; Blair D
    J Pharmacol Exp Ther; 1986 Oct; 239(1):124-31. PubMed ID: 2876091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C; Anderson KL; Itzhak Y
    Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1996 Mar; 299(1-3):21-8. PubMed ID: 8901003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR; White FJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.